 Michael Aubrey
Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transplantation, Haploidentical | 4 | 2024 | 21 | 0.820 |
Why?
| | HLA-DRB1 Chains | 4 | 2016 | 107 | 0.640 |
Why?
| | Epitopes | 4 | 2016 | 468 | 0.560 |
Why?
| | HLA-B Antigens | 3 | 2024 | 62 | 0.480 |
Why?
| | HLA Antigens | 5 | 2024 | 236 | 0.460 |
Why?
| | Vimentin | 2 | 2016 | 50 | 0.410 |
Why?
| | Graft vs Host Disease | 3 | 2024 | 238 | 0.380 |
Why?
| | Peptides, Cyclic | 2 | 2016 | 258 | 0.370 |
Why?
| | Arthritis, Rheumatoid | 3 | 2016 | 1106 | 0.340 |
Why?
| | Genetic Predisposition to Disease | 5 | 2016 | 2272 | 0.270 |
Why?
| | Alleles | 6 | 2024 | 849 | 0.250 |
Why?
| | Fetomaternal Transfusion | 1 | 2023 | 10 | 0.220 |
Why?
| | HLA-C Antigens | 1 | 2022 | 35 | 0.200 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 2022 | 78 | 0.190 |
Why?
| | Receptors, KIR | 2 | 2022 | 96 | 0.190 |
Why?
| | Recurrence | 1 | 2024 | 1016 | 0.180 |
Why?
| | Transplantation Conditioning | 2 | 2020 | 166 | 0.170 |
Why?
| | Evolution, Molecular | 1 | 2024 | 466 | 0.170 |
Why?
| | Tacrolimus | 1 | 2020 | 146 | 0.160 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 952 | 0.160 |
Why?
| | Pulmonary Alveolar Proteinosis | 1 | 2019 | 17 | 0.160 |
Why?
| | Islets of Langerhans | 3 | 1994 | 792 | 0.160 |
Why?
| | Pregnancy Complications | 1 | 2023 | 487 | 0.150 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2018 | 21 | 0.150 |
Why?
| | Donor Selection | 1 | 2018 | 74 | 0.140 |
Why?
| | Graft Rejection | 1 | 2020 | 569 | 0.140 |
Why?
| | HLA-DR Antigens | 2 | 2020 | 226 | 0.120 |
Why?
| | Autoimmune Diseases | 1 | 2019 | 422 | 0.120 |
Why?
| | Tissue Donors | 1 | 2018 | 399 | 0.120 |
Why?
| | Insulin | 3 | 1994 | 2313 | 0.120 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 1994 | 828 | 0.110 |
Why?
| | Peptides | 2 | 2016 | 903 | 0.110 |
Why?
| | International Cooperation | 1 | 2011 | 173 | 0.090 |
Why?
| | Cyclophosphamide | 2 | 2022 | 232 | 0.090 |
Why?
| | Cell Division | 1 | 1992 | 802 | 0.090 |
Why?
| | Algorithms | 1 | 2018 | 1632 | 0.090 |
Why?
| | Histocompatibility Testing | 2 | 2020 | 123 | 0.080 |
Why?
| | Protein Binding | 2 | 2016 | 2088 | 0.080 |
Why?
| | Gene Frequency | 3 | 2019 | 503 | 0.080 |
Why?
| | Humans | 22 | 2024 | 129705 | 0.080 |
Why?
| | Immunoglobulin E | 1 | 2010 | 354 | 0.080 |
Why?
| | Arachis | 1 | 2010 | 156 | 0.080 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2024 | 576 | 0.070 |
Why?
| | Amino Acids | 1 | 2011 | 470 | 0.070 |
Why?
| | Mycobacterium Infections | 1 | 1987 | 63 | 0.070 |
Why?
| | Peanut Hypersensitivity | 1 | 2010 | 208 | 0.070 |
Why?
| | Immunoglobulin G | 1 | 2010 | 842 | 0.060 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2022 | 360 | 0.060 |
Why?
| | Middle Aged | 7 | 2024 | 31103 | 0.060 |
Why?
| | Cricetinae | 3 | 1994 | 275 | 0.060 |
Why?
| | Haplotypes | 3 | 2014 | 476 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2011 | 3363 | 0.060 |
Why?
| | HLA-DP beta-Chains | 1 | 2024 | 84 | 0.050 |
Why?
| | Genotype | 2 | 2022 | 1836 | 0.050 |
Why?
| | HLA-A Antigens | 1 | 2022 | 53 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2024 | 7074 | 0.050 |
Why?
| | Myelodysplastic Syndromes | 1 | 2024 | 129 | 0.050 |
Why?
| | Adult | 6 | 2024 | 35595 | 0.050 |
Why?
| | Histocompatibility Antigens | 1 | 2022 | 109 | 0.050 |
Why?
| | Cell Line | 3 | 2016 | 2768 | 0.050 |
Why?
| | Interleukin-2 | 2 | 2000 | 433 | 0.050 |
Why?
| | Catechols | 2 | 2000 | 14 | 0.050 |
Why?
| | Hydroquinones | 2 | 2000 | 29 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2014 | 3601 | 0.050 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2022 | 196 | 0.050 |
Why?
| | Aged | 4 | 2024 | 22113 | 0.050 |
Why?
| | Female | 8 | 2024 | 68561 | 0.040 |
Why?
| | Biological Evolution | 1 | 2024 | 428 | 0.040 |
Why?
| | Young Adult | 3 | 2024 | 12363 | 0.040 |
Why?
| | Ligands | 1 | 2022 | 615 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2024 | 14669 | 0.040 |
Why?
| | Male | 7 | 2024 | 63544 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 764 | 0.040 |
Why?
| | Fibroblasts | 2 | 1994 | 946 | 0.040 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 149 | 0.040 |
Why?
| | Genotyping Techniques | 1 | 2018 | 72 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2016 | 4058 | 0.040 |
Why?
| | Graft Survival | 1 | 2020 | 525 | 0.040 |
Why?
| | Cell Transplantation | 1 | 1997 | 35 | 0.040 |
Why?
| | Allografts | 1 | 2018 | 138 | 0.030 |
Why?
| | Proinsulin | 1 | 1997 | 52 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2000 | 765 | 0.030 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2016 | 28 | 0.030 |
Why?
| | Mesocricetus | 2 | 1992 | 38 | 0.030 |
Why?
| | Collagen Type II | 1 | 2016 | 47 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2000 | 972 | 0.030 |
Why?
| | Cell Line, Transformed | 2 | 1992 | 140 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2016 | 370 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2016 | 356 | 0.030 |
Why?
| | Genetic Therapy | 1 | 1997 | 295 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2000 | 1208 | 0.030 |
Why?
| | Antigens, Viral, Tumor | 1 | 1994 | 6 | 0.030 |
Why?
| | Tobacco Smoke Pollution | 1 | 1997 | 233 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 673 | 0.030 |
Why?
| | Cell Adhesion | 1 | 1994 | 452 | 0.030 |
Why?
| | Cell Communication | 1 | 1994 | 292 | 0.030 |
Why?
| | Islets of Langerhans Transplantation | 1 | 1992 | 59 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2016 | 1151 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2016 | 2051 | 0.020 |
Why?
| | Cell Separation | 1 | 1992 | 313 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 2071 | 0.020 |
Why?
| | Autoantibodies | 1 | 2019 | 1463 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 6273 | 0.020 |
Why?
| | DNA | 1 | 1997 | 1406 | 0.020 |
Why?
| | Skin Tests | 1 | 2010 | 126 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 10299 | 0.020 |
Why?
| | Siblings | 1 | 2010 | 220 | 0.020 |
Why?
| | Glucose | 1 | 1994 | 977 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 1997 | 1911 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 4939 | 0.020 |
Why?
| | Ethambutol | 1 | 1987 | 25 | 0.020 |
Why?
| | Child, Preschool | 2 | 2014 | 10565 | 0.020 |
Why?
| | Rifampin | 1 | 1987 | 84 | 0.020 |
Why?
| | Animals | 5 | 1997 | 34733 | 0.020 |
Why?
| | HLA-B15 Antigen | 1 | 2006 | 13 | 0.020 |
Why?
| | Sequence Homology | 1 | 2006 | 40 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2006 | 298 | 0.020 |
Why?
| | United States | 1 | 2020 | 14078 | 0.010 |
Why?
| | Adolescent | 2 | 2014 | 20355 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2006 | 643 | 0.010 |
Why?
| | Child | 2 | 2014 | 20963 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2010 | 2783 | 0.010 |
Why?
| | Base Sequence | 1 | 2006 | 2161 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2006 | 2848 | 0.010 |
Why?
| | Ganglionic Stimulants | 1 | 2000 | 12 | 0.010 |
Why?
| | Plants, Toxic | 1 | 2000 | 22 | 0.010 |
Why?
| | Genetic Variation | 1 | 2006 | 936 | 0.010 |
Why?
| | Smoke | 1 | 2000 | 142 | 0.010 |
Why?
| | Nicotine | 1 | 2000 | 303 | 0.010 |
Why?
| | Depression, Chemical | 1 | 1997 | 22 | 0.010 |
Why?
| | Receptors, Transferrin | 1 | 1997 | 23 | 0.010 |
Why?
| | 3T3 Cells | 1 | 1997 | 151 | 0.010 |
Why?
| | Insulin, Long-Acting | 1 | 1997 | 61 | 0.010 |
Why?
| | Antioxidants | 1 | 2000 | 557 | 0.010 |
Why?
| | Cyclosporine | 1 | 1997 | 172 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1997 | 536 | 0.010 |
Why?
| | Transplantation, Homologous | 1 | 1997 | 404 | 0.010 |
Why?
| | Mice, Inbred NOD | 1 | 1997 | 579 | 0.010 |
Why?
| | Iron | 1 | 1997 | 285 | 0.010 |
Why?
| | Transfection | 1 | 1997 | 904 | 0.010 |
Why?
| | Cell Survival | 1 | 1997 | 1083 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 1997 | 706 | 0.010 |
Why?
| | RNA | 1 | 1997 | 877 | 0.010 |
Why?
| | Mice | 2 | 1997 | 16585 | 0.010 |
Why?
| | Liver | 1 | 1997 | 1848 | 0.000 |
Why?
| | Blood Glucose | 1 | 1997 | 2090 | 0.000 |
Why?
| | Cell Differentiation | 1 | 1992 | 1858 | 0.000 |
Why?
|
|
Aubrey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|